Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on May 16, 2024 11:47am
65 Views
Post# 36043539

RE:47 000 sq ft hope facility…

RE:47 000 sq ft hope facility…
alleyesonme wrote: Closure and land sale less expenses..745k...this makes no sense...who is buying and what are the terms of the deal...no public listings...value of this facility is closer to 10m + ..looking at commercial real estate in the region...q2 absolutely will show positive ebita...April 2024 signed GMP flower and extract agreement with pharma drug for distribution across Germany and the U.K...also filed a CBD DMF with health Canada....further acknowledgements on NDA's and ANDA submission made in the U.S referencing MPLs DMF...if approved the DMF is approved and MPL can manufacture, market, sell such approved pharmaceuticals superseding state law under federal approval as a pharmaceutical.


Are you suggesting that the proceeds from the sale total 745k and that it should have been closer to$10m?  Where did you get the 745k number from?  I don't recall hearing that in the call, is it in the MD&A?  Haven't read it yet.
<< Previous
Bullboard Posts
Next >>